IMSCO INC /MA/
10QSB, 2000-11-13
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Previous: SPORTS CLUB CO INC, 10-Q, EX-27, 2000-11-13
Next: RAINFOREST CAFE INC, 10-Q, 2000-11-13





                     U.S. SECURITIES AND EXCHANGE COMMISSION

                             Washington, D. C. 20549


                                   Form 10-QSB

              QUARTERLY REPORT PURSUANT TO SECTION 13 or 15 (d) OF
                       THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2000
                               ------------------

Commission file number 0-24520
                       -------


                            IMSCO TECHNOLOGIES, INC.
                            ------------------------
             (Exact name of registrant as specified in its charter)

            DELAWARE                                    04-3021770
            --------                                    ----------
(State or other jurisdiction of          (I.R.S. Employer Identification Number)
incorporation or organization)

8400 E. Crescent Parkway, Suite 600 Greenwood Village, Colorado       80111
---------------------------------------------------------------       -----
(Address of principal executive offices)                            (Zip Code)

Registrant's Telephone Number, including area code:                720-528-4043
                                                                   ------------

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  registrant  was
required  to file  such  reports),  and  (2) has  been  subject  to such  filing
requirements for the past 90 days.

                                 Yes X    No
                                    ---     ---

Indicate the number of shares  outstanding  of each of the  issuer's  classes of
common  equity,  as of  the  latest  practicable  date:  September  30,  2000  -
12,428,174.




<PAGE>


IMSCO TECHNOLOGIES, INC.

                                      INDEX

                                     PART I
                                     ------

Item 1. - Financial Statements:

     Independent Accountant's Report...................................... 3

     Consolidated Balance Sheet - September 30, 2000 (Unaudited).......... 4

     Consolidated Statement of Operations - For the Three and
     Nine Months Ended September 30, 2000 and 1999 (Unaudited)............ 5-6

     Consolidated Statement of Stockholders' (Deficit) - For
     Nine Months Ended September 30, 2000 (Unaudited)..................... 7

     Consolidated Statement of Cash Flows - For the Nine Months
     Ended September 30, 2000 and 1999 (Unaudited)........................ 8-9

     Notes to Consolidated Financial Statements (Unaudited)............... 10-11

Item 2.  Management's Discussion and Analysis or Plan of Operation........ 12-14

                                     PART II
                                     -------

Item 6.  Exhibits and Reports on Form 8-K................................. 15




                                       2
<PAGE>





                         INDEPENDENT ACCOUNTANT'S REPORT

To the Stockholders and Board of Directors of
   Imsco Technologies, Inc.
   Greenwood Village, Colorado

         We have reviewed the accompanying  consolidated  balance sheet of Imsco
Technologies,  Inc. and  Subsidiaries  as of September 30, 2000, and the related
consolidated  statements  of  stockholders'  (deficit) for the nine month period
then ended, and the consolidated statements of operations for the three and nine
month periods ended September 30, 2000 and the  consolidated  statements of cash
flows for the nine months ended September 30, 2000. These consolidated financial
statements are the responsibility of the Company's management.

         We conducted our review in accordance with standards established by the
American  Institute  of  Certified  Public  Accountants.  A  review  of  interim
financial  information consists principally of applying analytical procedures to
financial  data and making  inquiries of persons  responsible  for financial and
accounting matters. It is substantially less in scope than an audit conducted in
accordance with generally accepted auditing standards, the objective of which is
the expression of an opinion  regarding the  consolidated  financial  statements
taken as a whole. Accordingly, we do not express such an opinion.

         Based on our  review,  we are not aware of any  material  modifications
that should be made to the accompanying  consolidated  financial  statements for
them to be in conformity with generally accepted accounting principles.

         We have  not  reviewed  the  accompanying  consolidated  statements  of
operations for the three and nine month periods ended  September 30, 1999 or the
consolidated  statement  of cash flows for the nine months ended  September  30,
1999 and give no assurance on them.


                                                   MOORE STEPHENS, P. C.
                                                   Certified Public Accountants.

Cranford, New Jersey
November 1, 2000




                                       3
<PAGE>



PART I.  Financial Information
         ---------------------
Item 1.  Financial Statements

IMSCO TECHNOLOGIES, INC. AND SUBSIDIARIES
(A DEVELOPMENT STAGE COMPANY)

<TABLE>
<CAPTION>

CONSOLIDATED BALANCE SHEET AS OF SEPTEMBER 30, 2000
(UNAUDITED)

Assets:

Current Assets:

   <S>                                                                            <C>
   Cash ......................................................................    $     17,204
                                                                                  ------------

   Total Assets ..............................................................    $     17,204
                                                                                  ============

Liabilities and Stockholders' (Deficit):

Current Liabilities:

   Accounts Payable ..........................................................    $     27,075
   Accounts Payable to Be Assumed ............................................          96,491
   Accrued Expenses ..........................................................          66,500
   Due to Stockholders .......................................................          10,050
                                                                                  ------------

   Total Current Liabilities .................................................         200,116
                                                                                  ------------

Commitments and Contingencies ................................................            --
                                                                                  ------------

Stockholders' (Deficit):

   Series A Preferred Stock - Authorized 1,000,000 Shares at $.0001 Par Value;
     None Issued or Outstanding ..............................................            --

   Common Stock - Authorized 15,000,000 Shares at $.0001 Par Value;
     12,428,174 Shares Issued and Outstanding at September 30, 2000 ..........           1,243

   Additional Paid-in Capital - Common Stock .................................      12,717,110

   Deficit Accumulated During Developments Stage .............................     (11,530,357)

   Accumulated Deficit - Discontinued Operations .............................        (620,908)

   Less: Prepaid Advertising Credits .........................................        (750,000)
                                                                                  ------------

   Total Stockholders' (Deficit) .............................................        (182,912)
                                                                                  ------------

   Total Liabilities and Stockholders' (Deficit) .............................    $     17,204
                                                                                  ============
</TABLE>


  The Accompanying Notes Are an Integral Part of These Consolidated Statements.



                                       4
<PAGE>



IMSCO TECHNOLOGIES, INC. AND SUBSIDIARIES
(A DEVELOPMENT STAGE COMPANY)

CONSOLIDATED STATEMENT OF OPERATIONS
(UNAUDITED)

<TABLE>
<CAPTION>

                                                                                                                Cumulative
                                                                                                               Amounts from
                                                                                                               July 9, 1992
                                                                                                                (Inception
                                                                                                              of the Current
                                                 Three Months Ended                 Nine Months Ended        Development Stage)
                                                    September 30,                     September 30,           to September 30,
                                             2 0 0 0           1 9 9 9          2 0 0 0          1 9 9 9          2 0 0 0
                                             -------           -------          -------          -------          -------
   <S>                                   <C>              <C>              <C>              <C>              <C>
   Research and Development
     Expense ........................    $       --       $       --       $       --       $      8,911     $    301,925
   Salaries and Wages ...............            --               --               --            117,691          933,005
   Officer Salaries .................            --               --               --             30,807        1,102,500
   Payroll Taxes ....................            --               --               --             13,931          154,803
   Outside Labor ....................            --               --               --               --            191,136
   Write-Down of Prepaid
     Advertising Credits ............         628,496             --            628,496             --            628,496
   Professional and Consulting Fees .          15,000          105,258           91,800          181,003        1,332,460
   Professional and Consulting Fees -
     Non-Cash .......................           1,500             --              5,250             --          2,192,789
   Rent .............................            --               --               --              9,269          165,288
   Rent- Related Party ..............            --               --               --              1,750            5,500
   Insurance ........................            --              4,400             --             27,801          190,879
   Travel and Business Meeting ......            --               --               --             11,321          189,250
   Auto Expense .....................            --               --               --              5,448           66,217
   Telephone and Utilities ..........            --               --               --              6,014           67,416
   Office Expense ...................             626              190            3,670            4,355          146,834
   Equipment Rental .................            --               --               --              2,781           36,080
   Corporate Fees ...................            --               --               --               --             69,981
   Advertising ......................            --               --               --             12,000          330,703
   Depreciation and Amortization ....            --             24,953             --             29,993           53,920
   Litigation Settlement ............            --               --               --               --          1,644,642
   Franchise Tax ....................            --               --               --               --              1,987
                                         ------------     ------------     ------------     ------------     ------------

   Total General, Administrative
     and Development Expense ........         645,622          134,801          729,216          463,075        9,805,811
                                         ------------     ------------     ------------     ------------     ------------

Other Income (Expense):
   Dividend and Interest Income .....            --               --               --               --             11,633
   Interest Expense .................            --            (16,900)      (1,145,824)        (252,770)      (2,218,504)
   Loss on Sale of Fixed Assets .....            --               --               --               --            (44,072)
                                         ------------     ------------     ------------     ------------     ------------

   Other (Expenses) - Net ...........            --            (16,900)      (1,145,824)        (252,770)      (2,250,943)
                                         ------------     ------------     ------------     ------------     ------------

   (Loss) Before Income Taxes .......        (645,622)        (151,701)      (1,875,040)        (715,845)     (12,056,754)

Benefit from Income Tax .............          52,000             --            179,000             --            179,000
                                         ------------     ------------     ------------     ------------     ------------

   (Loss) Before Extraordinary

     Gain ...........................        (593,622)        (151,701)      (1,696,040)        (715,845)     (11,877,754)

Extraordinary Gain - Net of
   Income Taxes of $52,000 and
   $179,000 for the Three and Nine
   Months Ended September 30,
   2000, Respectively ...............          98,945             --            347,397             --            347,397
                                         ------------     ------------     ------------     ------------     ------------

   Net (Loss) .......................    $   (494,677)    $   (151,701)    $ (1,348,643)    $   (715,845)    $(11,530,357)
                                         ============     ============     ============     ============     ============
</TABLE>

  The Accompanying Notes Are an Integral Part of These Consolidated Statements.


                                       5
<PAGE>


IMSCO TECHNOLOGIES, INC. AND SUBSIDIARIES
(A DEVELOPMENT STAGE COMPANY)

CONSOLIDATED STATEMENT OF OPERATIONS
(UNAUDITED)

<TABLE>
<CAPTION>

                                                    Three Months Ended                  Nine Months Ended
                                                       September 30,                      September 30,

                                                 2 0 0 0          1 9 9 9            2 0 0 0          1 9 9 9
                                                 -------          -------            -------          -------

Basic (Loss) Per Share of Common
   Stock:

   <S>                                       <C>               <C>               <C>                <C>
   (Loss) Before Extraordinary Gain          $         --      $      (.02)      $       (.10)      $      (.09)
   Extraordinary Gain ................                 --               --                .03                --
                                             --------------    -------------     --------------     -------------

   Net (Loss) ........................       $         --      $      (.02)      $       (.07)      $      (.09)
                                             ==============    =============     ==============     =============

Basic Weighted Average Shares of
   Common Stock Outstanding ..........           12,426,762        8,010,657         11,388,880         8,010,657
                                             ==============    =============     ==============     =============

Diluted Income (Loss) Per
   Share of Common Stock:

   (Loss) Before Extraordinary Gain          $         --      $      (.02)      $       (.10)      $      (.09)
   Extraordinary Gain ................                 --               --                .02                --
                                             --------------    -------------     --------------     -------------

   Net (Loss) ........................       $         --      $      (.02)      $       (.08) $           (.09)
                                             ==============    =============     ==============     =============

Basic and Diluted Weighted Average
   Common Shares Outstanding .........           12,426,762        8,010,657         11,388,880         8,010,657
                                             ==============    =============     ==============     =============
</TABLE>

  The Accompanying Notes Are an Integral Part of These Consolidated Statements.


                                       6
<PAGE>


<TABLE>
<CAPTION>

IMSCO TECHNOLOGIES, INC. AND SUBSIDIARIES
(A DEVELOPMENT STAGE COMPANY)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)
(UNAUDITED)

                                                                                                                         Deficit
                     Series A Convertible                                                 Accumulated   Accumulated       Total
                     --------------------                                                 -----------   -----------       -----
                       Preferred Stock   Common Stock   Paid-in Capital        During       Deficit       Prepaid     Stockholders'
                       ---------------   ------------   ---------------        ------       -------       -------     -------------
                Number of           Number of         Preferred   Common    Development   Discontinued   Advertising     Equity
                ---------           ---------         ---------   ------    -----------   ------------   -----------     ------
                 Shares    Amount    Shares    Amount  Stock       Stock       Stage       Operations      Credits      (Deficit)
                 ------    ------    ------    ------  -----       -----       -----       ----------      -------       -------

<S>              <C>      <C>      <C>         <C>    <C>       <C>         <C>             <C>         <C>           <C>
Balance -
December 31,
1999             45,000   $   5    8,928,174   $ 893  $224,995  $10,480,703 $(10,181,714)   $(620,908)  $ (1,378,496) $(1,474,522)

Issuance of
Shares Upon
Conversion
of Notes            --       --     2,520,000     252       --    1,433,968           --          --             --     1,434,220

Issuance of
Shares Upon
Conversion
of Notes            --       --       104,635      10       --       84,745           --          --             --        84,755

Issuance of
Shares Upon
Conversion
of Notes            --       --       495,365      50       --      450,732           --          --             --       450,782

Issuance of
Shares for
Services            --       --        25,000       2       --        4,998           --          --             --         5,000
Exercise of
Stock Options       --       --       100,000      10       --       16,990           --          --             --        17,000

Exercise of
Warrants            --       --        20,000       2       --       16,248           --          --             --        16,250

Conversion of
Preferred
Stock           (45,000)     (5)      225,000      23 (224,995)     224,977           --          --             --           --

Issuance of
Shares for
Services            --       --        10,000       1       --        3,749           --          --             --         3,750

Write-Down of
Prepaid
Advertising
Credits             --       --           --      --        --           --           --          --         628,496      628,496

Net (Loss)          --       --           --      --        --           --   (1,348,643)         --             --    (1,348,643)
                --------  -------  ----------  ------   ------  ----------- ------------  ------------     ---------   ----------

Balance -
September
30, 2000
(Unaudited)         --    $  --    12,428,174  $1,243   $   --  $12,717,110 $(11,530,357) $   (620,908)    $(750,000)  $ (182,912)
                ========  =======  ==========  ======   ======  =========== ============  ============     =========   ==========
</TABLE>

  The Accompanying Notes Are an Integral Part of These Consolidated Statements.


                                       7
<PAGE>


IMSCO TECHNOLOGIES, INC. AND SUBSIDIARIES
(A DEVELOPMENT STAGE COMPANY)

CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)

<TABLE>
<CAPTION>

                                                                                                 Cumulative
                                                                                                   Amounts
                                                                                                    from
                                                                                                July 9, 1992
                                                                                                (Inception of
                                                                                                 the Current
                                                                                                 Development
                                                                      Nine months ended           Stage) to
                                                                         September 30           September 30,
                                                                    2 0 0 0        1 9 9 9         2 0 0 0
                                                                    -------        -------         -------

Operating Activities:

   <S>                                                           <C>            <C>             <C>
   Net (Loss) Before Extraordinary Gain                          $(1,696,040)   $   (715,845)   $(11,877,754)
                                                                 -----------    ------------    ------------
   Adjustments to Reconcile Net (Loss) to Net Cash
     (Used for) Operating Activities:
     Extraordinary Gain - Sale of Technology ..............          347,397            --           347,397
     Decrease (Increase) in Due from Officers .............             --             2,980            (120)
     Contract Services Paid in Stock ......................            8,750         101,961       2,182,196
     Depreciation .........................................             --            29,993          56,532
     Interest Expense - Deferred Financing Cost ...........             --            82,577         299,085
     Interest Paid with Common Stock ......................           11,584            --           328,613
     Grant of Options and Warrants for Past Services ......             --            45,000         897,659
     Interest Expense Warrant Discount ....................           29,470            --            50,470
     Amortization of Prepaid Advertising Credits ..........             --              --           229,674
     Amortization - Discount Note Payable .................            3,056            --            19,862
     Interest Expense - Beneficial Conversion Feature .....        1,101,714            --         1,301,714
     Loss on Disposal of Property and Equipment ...........             --              --            44,072
     Stock Issued to Settle Litigation ....................             --              --            56,250
     Note Issued to Settle Litigation .....................             --              --            50,000
     Write-Down of Prepaid Advertising Credits ............          628,496            --           628,496

     (Increase) Decrease In:
       Other Current Assets ...............................             --              --            20,200
       Security Deposits ..................................             --             1,000           4,675
       Accounts Receivable ................................             --              --             2,998

     Increase (Decrease) in:
       Accounts Payable ...................................          (55,821)        (76,472)        (37,376)
       Accrued Payroll Taxes ..............................             --           (11,369)           --
       Accrued Expenses ...................................           48,458          80,186       1,604,892
       Accrued Interest ...................................             --            53,472         130,022
       Accrued Marketing Fees .............................             --           (53,000)           --
       Accrued Salaries ...................................             --            33,180            --
       Accounts Payable Subject to Transfer ...............         (431,860)           --            96,491
                                                                 -----------     -----------     -----------

       Total Adjustments ..................................        1,691,244         289,508       8,313,802
                                                                 -----------     -----------     -----------

   Net Cash - Operating Activities - Forward ..............      $    (4,796)    $  (426,337)    $(3,563,952)
</TABLE>

 The Accompanying Notes Are an Integral Part of These Consolidated Statements.


                                       8
<PAGE>


IMSCO TECHNOLOGIES, INC. AND SUBSIDIARIES
(A DEVELOPMENT STAGE COMPANY)

CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)

<TABLE>
<CAPTION>

                                                                                                  Cumulative
                                                                                                    Amounts
                                                                                                     from
                                                                                                 July 9, 1992
                                                                                                 (Inception of
                                                                                                  the Current
                                                                                                  Development
                                                                       Nine months ended           Stage) to
                                                                          September 30           September 30,
                                                                     2 0 0 0        1 9 9 9         2 0 0 0
                                                                     -------        -------         -------

   <S>                                                            <C>             <C>             <C>
   Net Cash - Operating Activities - Forwarded ............       $    (4,796)    $  (426,337)    $(3,563,952)
                                                                  -----------     -----------     -----------

Investing Activities:

   Prepaid Research Testing ...............................              --              --            (7,734)
   Purchase of Fixed Assets ...............................              --              --          (118,212)
   Proceeds From Sale of Fixed Assets .....................              --              --            21,000
                                                                  -----------     -----------     -----------

   Net Cash - Investing Activities ........................              --              --          (104,946)
                                                                  -----------     -----------     -----------

Financing Activities:

   Convertible Note Payable ...............................              --           545,000         545,000
   Proceeds from Notes Payable ............................              --              --           775,000
   Proceeds form Preferred Stock ..........................              --              --           225,000
   Bond Discount ..........................................              --            55,000          55,000
   Loans From Stockholders ................................              --              --           (24,500)
   Payment on Loans from Stockholders .....................              --              --            52,050
   Proceeds from Exercise of Options and Warrants .........            22,000            --            22,000
   Proceeds from Issuance of Common Stock .................              --              --         2,247,304
   Payment of Notes Payable ...............................              --          (196,645)       (196,645)
                                                                  -----------     -----------     -----------

   Net Cash - Financing Activities ........................            22,000         403,355       3,700,209
                                                                  -----------     -----------     -----------

   Net Increase (Decrease) in Cash ........................            17,204         (22,982)         31,311

Cash - Beginning of Periods ...............................              --            22,992         (14,107)
                                                                  -----------     -----------     -----------

   Cash - End of Periods ..................................       $    17,204     $        10     $    17,204
                                                                  ===========     ===========     ===========

Supplemental Disclosures of Cash Flow Information:
   Cash paid during the periods for:
     Interest .............................................       $      --       $      --       $     9,047
     Income Taxes .........................................       $      --       $      --       $      --
</TABLE>

Supplemental Schedule of Non-Cash Investing and Financing Activities:

   During the quarter ending March 31, 2000, the Company issued 3,120,000 shares
of Common Stock upon conversion of past due notes of $708,217, past due interest
of $130,022 and current interest of $11,584.

   During the quarter ending June 30, 2000, the Company issued 25,000 shares for
services rendered.

   During the quarter  ending  September  30, 2000,  the Company  issued  10,000
shares for services rendered.

 The Accompanying Notes Are an Integral Part of These Consolidated Statements.


                                       9
<PAGE>


IMSCO TECHNOLOGIES, INC. AND SUBSIDIARIES
(A DEVELOPMENT STAGE COMPANY)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Information as of September 30, 2000 and 1999 is Unaudited)


(1) BASIS OF PRESENTATION

The accompanying unaudited financial statements have been prepared in accordance
with generally accepted accounting principles for interim financial information.
Accordingly,  they do not  include all  information  and  footnotes  required by
generally accepted accounting principles for complete financial  statements.  In
the opinion of  management,  all  adjustments  (consisting  of normal  recurring
accruals)  considered  necessary  for a fair  presentation  have been  included.
Results for the three  months and nine months  ended  September  30,2000 are not
necessarily  indicative  of the results that may be expected for the fiscal year
ended  December 31, 2000.  For further  information,  refer to the  consolidated
financial  statements  and footnotes  thereto  included in the Company's  annual
report on Form 10-KSB for the year ended December 31, 1999.

PRINCIPLES OF CONSOLIDATION - The consolidated  financial statements include the
accounts of the Company and its  subsidiaries  Decaf Products,  Inc. ("DPI") and
BioElectric Separation and Testing, Inc. ("BEST"). All significant inter-company
accounts and transactions have been eliminated in consolidation.

EARNINGS  (LOSS) PER SHARE - Earnings  (loss) per share of common stock reflects
the weighted average number of shares outstanding for each period. The Financial
Accounting  Standards Board ("FAS has issued  Statement of Financial  Accounting
Standards  ("SFAS")  No. 128,  "Earnings  Per  Share",  which is  effective  for
financial  statements  issued  for  periods  ending  after  December  15,  1997.
Accordingly,  (loss) per share  data in the  financial  statements  for the nine
months  September  30, 2000,  and for the nine months ended  September 30, 1999,
have been calculated in accordance with SFAS No. 128.

SFAS No. 128 supercedes  Accounting  Principles  Board Opinion No. 15, "Earnings
Per  Share,"  and  replaces  its  primary  earnings  per share  with a new basic
earnings per share  representing the amount of earnings for the period available
to each share of common stock outstanding during the reporting period.  SFAS No.
128 also requires a dual presentation of basic and diluted earnings per share on
the face of the statement of operations for all companies  with complex  capital
structures.  Diluted  earnings per share reflects the amount of earnings for the
period available to each share of common stock outstanding  during the reporting
period,  while giving effect to all dilutive  potential  common shares that were
outstanding during the period,  such as common shares that could result from the
potential exercise or conversion of securities into common stock.

The  computation  of diluted  earnings  per share  does not  assume  conversion,
exercise or contingent  issuance of securities  that would have an  antidulutive
effect on earnings  per share (i.e.,  increasing  earnings per share or reducing
loss per share).  The dilutive  effect of  outstanding  options and warrants and
their   equivalents  are  reflected  in  dilutive  earnings  per  share  by  the
application  of the treasury  stock method which  recognizes the use of proceeds
that could be obtained  upon the  exercise of options and  warrants in computing
diluted  earnings  per share.  It  assumes  that any  proceeds  would be used to
purchase common stock at the average market price during the period. Options and
warrants will have a dilutive  effect only when the average  market price of the
common  stock  during the period  exceeds the  exercise  price of the options or
warrants.  At September 30,2000, the Company had 1,150,000 options and 1,809,645
warrants issued and outstanding to purchase common stock that could  potentially
dilute basic earnings per share in the future.

STOCK OPTIONS AND SIMILAR  EQUITY  INSTRUMENTS - On January 1, 1996, the Company
adopted  the  disclosure  requirements  of  Statement  of  Financial  Accounting
Standards ("SFAS") No. 123, "Accounting for Stock-Based Compensation," for stock
options  and  similar  equity  instruments  (collectively  "Options")  issued to
employees  and  directors,  however,  the  Company  will  continue  to apply the
intrinsic  value based  method of  accounting  for options  issued to  employees
prescribed by Accounting  Principles  Board ("APB") Opinion No. 25,  "Accounting
for Stock  Issued to  Employees"  rather  than the fair  value  based  method of
accounting  prescribed by SFAS No. 123. SFAS No.123 also applies to transactions
in which an entity issues its equity  instruments  to acquire goods and services
from  non-employees.  Those transactions must be accounted for based on the fair
value of the consideration  received or the fair value of the equity instruments
issued, whichever is more reliably measurable.


                                       10
<PAGE>


IMSCO TECHNOLOGIES, INC. AND SUBSIDIARIES
(A DEVELOPMENT STAGE COMPANY)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Information as of September 30, 2000 and 1999 is Unaudited)


(2) STOCKHOLDERS' EQUITY

For the nine months ended  September  30, 2000,  3,145,000  common shares with a
market value of $1,974,757 were issued for past due notes,  accrued expenses and
interest of $854,823 resulting in a charge to operations of $1,119,934.

(3) LEGAL PROCEEDINGS

A complaint  and summons was filed  against the Company by Kutchin & Rufo, PC in
Suffolk county Superior Court in Massachusetts seeking recovery of approximately
$11,800 plus damages for legal services rendered during the period April 1, 1997
through  December 31, 1999.  The Company  satisfied the liability in full in May
2000.

(4) GOING CONCERN

The  accompanying  financial  statements  have been prepared in conformity  with
generally accepted accounting principles, which contemplates continuation of the
Company  as a  going  concern  and  realization  of  assets  and  settlement  of
liabilities and commitments in the normal course of business.

As shown in the accompanying  financial  statements,  the Company incurred a net
loss before extraordinary gain of $1,696,040 for the nine months ended September
30,  2000.  The  Company  also  reported  a gain  from the sale of  patents  and
technology to a former officer and director of $526,397,  net of income taxes of
$179,000.  The  significant  operating loss as well as the uncertain  sources of
financing,  creates an uncertainty  about the Company's ability to continue as a
going concern.  Management of the Company has developed a business plan to merge
with a private  company.  The Company will also seek financing  through a public
offering.  The financial statements do not include any adjustments that might be
necessary if the Company is unable to continue as a going concern.

The continuation of the Company as a going concern is dependent upon the success
of these plans.

There can be no assurance that management's plans to reduce operating losses and
obtain additional financing to fund operations will be successful. The financial
statements do not include any  adjustments  relating to the  recoverability  and
classification  of  recorded  assets,  or  the  amounts  and  classification  of
liabilities  that might be necessary in the event the Company cannot continue in
existence.

(5) COMMITMENTS AND CONTINGENCIES

The Company has entered into an agreement with SonicPort.Com,  Inc.("SonicPort")
to sell its Media  Credits for 694,400  restricted  shares of  SonicPort  common
stock having an estimated  fair value of  $750,000.  SonicPort  will pay for the
Media  Credits on a dollar for dollar  basis as the Media is used.  If SonicPort
has not used all of the Media Credits by July 1, 2001 Imsco shall be entitled to
all the  remaining  shares.  Therefore,  the Company has written  down its Media
Credits to fair value.  Consummation of the transaction is dependent upon future
events.


                                       11
<PAGE>


(6) EXTRAORDINARY GAIN

In February  2000,  the Company  entered  into an agreement  with a  corporation
controlled by a former  officer and director to sell the  Company's  patents and
technology in exchange for $50,000 and the  assumption of  substantially  all of
the Company's accounts payable. As of September 30, 2000, the former officer and
director  had paid the Company  $50,000 and  discharged  or assumed  $476,397 of
liabilities. The Company recorded a pre-tax gain of $526,397 for the nine months
ending September 30, 2000.

                                . . . . . . . . .


                                       12
<PAGE>


ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION

GENERAL

During the past  twelve  months,  we have  completed  a series of major steps to
completely  restructure  Imsco.  The  restructuring  was  necessary  because the
implementation of our decaffeination business had failed miserably. Our goals at
this time are two-fold:  first, we want to describe the specific actions that we
have taken to clean up the  Company;  and second,  we want to share with you our
strategy and the specific  courses of action that we are pursuing to salvage and
enhance value for shareholders.

The first step we took was to completely  close down our failing  decaffeination
technology business. This was accomplished by negotiating a separation agreement
with  former   management   whereby  all  remaining   employees  and  management
voluntarily  resigned from the Company. We also closed the Company's two offices
in Massachusetts and New York.  Simultaneous with these actions,  we reduced the
Board of Directors from four people to two.  Currently,  the Company has no paid
employees, no leases, and no monthly obligations.

The  second  step  in  our  plan  was  to  eliminate  or  reduce  the  Company's
liabilities,  which at the  time  exceeded  $550,000.  We  accomplished  this by
executing  an  Assignment  and  Assumption   Agreement  (the  "Agreement")  with
ElectroStatic  Products,  Inc. ("ESPI"),  a new company under the control of our
former Chief  Executive  Offer.  In  consideration  for an assignment of Imsco's
patents to ESPI, ESPI agreed:  (1) to assume all of Imsco's  existing  payables;
(2) to pay Imsco $50,000 in cash;  and (3) to grant Imsco a 5% royalty on future
sales resulting from Imsco's  patented  technologies.  As of September 30, 2000,
ESPI had paid  the  Company  $50,000  and  discharged  or  assumed  $476,397  of
liabilities.  The Company recorded a pre-tax gain of $526,397 in the nine months
ending September 30, 2000 and a pre-tax gain of $63,179 for the quarter.

The third step was to simplify and strengthen the Company's  capital  structure.
In  September  1999,  Imsco had 7.8  million  shares of Common  Stock and 45,000
shares of Preferred  stock,  convertible  into 225,000  shares of Common  Stock,
outstanding.  In addition,  we were in default on $390,000 of Senior Convertible
Promissory  Notes as well as $600,000 of Convertible  Debentures.  Both of these
liabilities were structured as "toxic convertibles" or "death spirals", which is
the name  given to debts that are  convertible  into a  theoretically  unlimited
number of shares of Common  Stock,  potentially  causing a massive  dilution  of
existing shareholders equity. In total, we issued 3,120,000 shares of new Common
Stock to retire these debts and to eliminate  any senior claims on the Company's
remaining assets.

Finally,  Imsco was a defendant in two lawsuits  brought by a former  consultant
and a  director  of the  Company.  While  we  believed  the  cases  had no merit
whatsoever, we faced two unpleasant realities. First, the Company had no cash to
continue to litigate  the  matters.  And second,  we had few, if any,  strategic
options  available  to us with the cloud of  lawsuits  hanging  over our  heads.
Ultimately, we chose a pragmatic solution and settled these suits by issuing the
plaintiffs 550,000 shares of new Common Stock.

As of  September  30,  we had  12,428,174  shares  of Common  Stock  issued  and
outstanding.  In addition,  there are a total of 2,839,645  options and warrants
outstanding  with a weighted  exercise price of $1.04 per share.  Of this total,
300,000 options/warrants expire in 2000 and another 469,534 expire in 2001.

Although  it has  come at the  cost of a  substantial  dilution  to our  current
shareholders'  equity, we have successfully  stopped the monthly hemorrhaging of
red ink, simplified the capital structure, and


                                       13
<PAGE>


cleared up all  litigation.  As of September  30, ESPI had secured  satisfactory
releases of just over 73% of the  accounts  payable  and paid  $50,000 to Imsco.
Moreover, we are reasonably confident that ESPI can successfully settle with the
vast majority of the remaining creditors,  thus finally making Imsco a debt free
Company.  In short, after being very deeply in the hole, we are effectively back
to zero.

Our  strategy  for  salvaging  and  perhaps   enhancing  some  value  for  Imsco
shareholders  rests solely on the  prospect of merging with an exciting  private
company.  A private  company is motivated to enter into such a merger because it
desires an immediate  access to the capital  markets that it would otherwise not
have.


                                       14
<PAGE>


We are speaking and meeting with several private  companies with the expectation
of entering  into a definitive  merger  agreement  by the late third  quarter or
early fourth  quarter of this year.  Once such an agreement is reached,  we will
mail you a proxy asking you to vote on the merger  proposal.  In total, it takes
anywhere  between two and four months from the time a proxy is  submitted to the
SEC to the time when a merger can be consummated. If we are lucky enough to meet
the timetable  listed above, we would anticipate a merger being completed in the
late first  quarter or early second  quarter of 2001.  However,  there can be no
assurances that any of these events will occur on this schedule, if at all. Such
a merger would result in Imsco  shareholders  owning only a small  percentage of
the merger partner.

Statements  included in this  "Management's  Discussion  and Analysis or Plan of
Operation" Section,  and in other sections of the Report and in prior and future
filings by the Company  with the  Securities  and  Exchange  Commission,  in the
Company's prior and future press releases and in historical or current facts are
"forward-looking  statements"  made  pursuant to safe harbor  provisions  of the
Private  Securities  Litigation  Reform  Act of 1995 and are  subject to certain
risks and  uncertainties  that could cause actual  results to differ  materially
from those  presently  anticipated  or projected.  The Company wishes to caution
readers not to place  undue  reliance  on any such  forward-looking  statements,
which speak only as of the date made.  There are  numerous  risk factors that in
some cases have  affected and in the future could  affect the  Company's  actual
results and could cause the Company's actual financial and operating performance
to differ materially from that expressed in any forward-looking  statement.  The
following  discussion and the analysis  should be read in  conjunction  with the
Financial Statements and notes to Financial Statements which appear elsewhere in
this report.

RESULTS OF OPERATIONS  FOR NINE MONTHS ENDED  SEPTEMBER 30, 2000;  COMPARED WITH
SEPTEMBER 30, 1999

Net losses  before  extraordinary  items  increased  from  $715,845 for the nine
months  ended  September  30,  1999 to  $1,875,040  for the  nine  months  ended
September 30, 2000. The Company had no revenue or operating  income for the nine
month periods ended September 30, 1999 and 2000 from continuing operations.  The
general  administrative  and  development  expenses  were  $729,216 for the nine
months ended  September  30, 2000, in comparison to $463,075 for the nine months
ended  September  30,  1999.  The  increase  is from the  write-down  of prepaid
advertising  costs of $628,496  which offset the  decrease in expenses  from the
elimination  of all  payroll,  employee  related  expenses  and from the savings
realized from closing two offices.  Interest expenses increased from $252,770 in
1999 to  $1,145,824  in 2000.  The increase in these costs from 1999 to 2000 was
the result of a charge of $1,101,714 for the reduction in the  conversion  price
of $600,000  Convertible Notes from 75% of market price on the day of conversion
to $.25 per share,  and a  reduction  in the  conversion  price of  $143,355  of
Convertible  Notes from 80% of the average bid price to $.29 per share. A charge
of  $18,220  was the  result of a  reduction  in the  exercise  price of 120,000
warrants to $.0001 per share.

At September 30, 2000, the Company had $17,204 of cash and total  liabilities of
$200,116 and total stockholders' deficit of $(182,912).

RESULTS OF OPERATIONS FOR THREE MONTHS ENDED  SEPTEMBER 30, 2000;  COMPARED WITH
SEPTEMBER 30, 1999

The net loss  before  extraordinary  items and income tax benefit  increased  to
$645,622 for the quarter


                                       15
<PAGE>


ending  September  30, 2000 from  $151,701  for the prior year because a $88,758
decrease in professional and consulting fees, elimination of $16,900 of interest
expense and  reductions in most other  expenses were offset by the write-down of
$628,496 of prepaid  advertising  credits.  The Company recorded a gain from the
sale of patents and  technologies  of $150,945 net of an income tax provision of
$52,000 in the quarter ending September 30, 2000.


                                       16
<PAGE>


LIQUIDITY AND CAPITAL RESOURCES

The Company had a working capital  deficit  position as of September 30, 2000 of
approximately  $183,000  as compared to a working  capital  deficit  position of
approximately  $1,475,000 as of December 31, 1999. The working  capital  deficit
position was reduced  during the three month period  ending  September  30, 2000
when the Company  received  $10,000 and had $53,179 of liabilities  assumed by a
former  officer and director as partial  consideration  from the sale of patents
and technologies.

For the three months ended March 31, 2000, the working capital deficit  position
was reduced  when the Company  satisfied  all past due notes and interest in the
amount of $849,823  by issuing  3,120,000  shares of common  stock with a market
value of $1,969,757.

The Company had negative net worth or a stockholders'  deficit of  approximately
$183,000  as of  September  30,  2000 as  compared  to a  negative  net worth or
stockholders'  deficit of approximately  $1,475,000 as of December 31, 1999. The
stockholders'  deficit  was  reduced  by the gain  from the sale of  patent  and
technologies  of $526,397  and from the exchange of common stock for $849,823 of
past  due  notes  and  interest.  The  Company  had an  accumulated  deficit  of
$12,151,265  at September 30, 2000, in comparison to an  accumulated  deficit of
$10,802,622 as of December 31, 1999. The increase in the accumulated  deficit is
primarily related to continuing operating costs without any operating income.

The Company does not  currently  possess a bank source of financing  and has not
had any revenues.  The Company  cannot be certain that it's existing  sources of
cash will be adequate to meet its liquidity requirements. Therefore, the Company
is considering the following options to meet its liquidity requirements:

(a)  attempting to raise additional funds through the sale of equity  securities
     to persons or entities who are not presently stockholders of the Company;

(b)  should insufficient funds be available from the foregoing sources, reducing
     the  Company's  present  rate  of  expenditures,   which  might  materially
     adversely affect the ability of the Company to produce competitive products
     and services and to market them effectively.

The  Company's  plan of operation  for the next 12 months is to continue to seek
the acquisition of assets, properties or businesses that may benefit the Company
and  its  stockholders.   Management   anticipates  that  to  achieve  any  such
acquisition,  the  Company  will issue  shares of its  common  stock as the sole
consideration for such acquisition.

During the next 12 months,  in  addition  to its  efforts to reduce  outstanding
accounts payable, the Company's foreseeable cash requirements will relate to (i)
maintaining  the Company in good  corporate  standing in the State of  Delaware,
(ii)  costs  incurred  to remain a  reporting  company  in  compliance  with the
Securities  Exchange Act of 1934, as amended (the "Exchange Act"), and (iii) the
payment  of  expenses  associated  with  reviewing,  investigating  and  legally
documenting  any  potential  business  venture.  To  maintain  its  status  as a
reporting  company  under the  Exchange  Act, the Company will need to incur the
costs of an annual audit of the Company's financial  statements,  and the filing
of Forms  10-KSB,  10-QSB  and any other  periodic  reports as  required  by the
Exchange Act. It is a certainty that  additional  funds will be required to meet
even the minimal  obligations  envisioned herein.  Such funds may be advanced by
management  or  stockholders  in return for the issuance of common shares of the
Company or as loans to the Company, although there is no commitment to make such
loans or advances from these parties. No assurance can be given that the Company
will be able to raise these funds.

Unless the Company is able to generate revenues or obtain  additional  financing
in the future,  the continuing  losses incurred by the Company raise substantial
doubt about the Company's ability to continue as a going concern.  The Company's
ability to obtain funds through an offering of its equity or debt  securities is
limited by its lack of revenue.  In any event,  there is no  assurance  that any
expenditure  reductions,  financings  or other  measures that the Company may be
able to effect will enable it to meet its working capital requirements.


                                       17
<PAGE>


                                     PART II

                                Other Information

ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K.

       (a)    Exhibits.

              Exhibit No. 27 - Financial Data Schedule

       (b)    Reports on Form 8-K.

       The Company filed no report on Form 8-K during the quarterly period ended
September 30, 2000.


                                       18
<PAGE>


                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

                                                  IMSCO Technologies, Inc.



November 10, 2000                                  By: /s/  Timothy J. Keating
                                                      -------------------------
                                                      Timothy J. Keating
                                                      Chief Executive Officer



                                       19





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission